Workflow
中医络病理论
icon
Search documents
2024-2025年度家庭常备药上榜品牌揭晓 连花清咳片登榜
Zheng Quan Ri Bao Wang· 2025-11-19 09:13
一项由全国8家单位参与、共纳入480例患者的连花清咳片治疗急性气管-支气管炎的随机双盲、安慰剂 对照、多中心研究显示:连花清咳片具有确切的快速止咳和化痰作用,疾病疗效总有效率为92.39%, 且临床用药安全,研究期间未发现与该药相关的不良反应。 11月18日,由家庭医生在线主办的"2024-2025年度家庭常备药上榜品牌"颁奖典礼在南京举行,以岭药 业(002603)连花清咳片荣获家庭常备药(止咳祛痰)上榜品牌。 呼吸系统疾病是一种常见病、多发病,而咳嗽是呼吸系统疾病最常见的临床症状,常从发病起始持续至 恢复期,严重影响生活质量。因此,如何有效止咳化痰成为很多家庭的困扰。 连花清咳片作为以中医络病理论为指导,集合传统经典名方及临床实践研制的创新中药,具有清肺、化 痰、止咳多重功效,广泛应用于缓解感冒、流感、肺炎、慢阻肺急性发作等多种呼吸道疾病引起的咳 嗽、咳痰症状。 系列研究证实,连花清咳片具有明显的抗病毒、抑菌作用,有效控制气道炎症;对咳嗽有显著的抑制作 用,能减少咳嗽频次、缩短咳嗽时间、提高咳嗽消失率;同时,通过减少痰液生成,降低痰液黏稠度, 促进痰液排出,有效解决痰液阻滞的问题,畅通呼吸道;还可以保护气 ...
股市必读:以岭药业(002603)11月12日董秘有最新回复
Sou Hu Cai Jing· 2025-11-12 18:15
Core Viewpoint - Yiling Pharmaceutical is focusing on internationalization through innovation, brand development, and expanding its influence in traditional Chinese medicine (TCM) globally [2][5]. Group 1: Internationalization Efforts - Yiling Pharmaceutical aims to enhance the international brand influence of TCM by promoting the theory of "Luo Disease" abroad, establishing over 130 professional committees in various countries [2]. - The company has developed a new academic discipline in TCM, creating textbooks and courses in over 40 higher education institutions domestically [2]. - Yiling has received significant recognition for its innovative contributions to TCM, including six national major scientific achievement awards [2]. Group 2: Product Development and Market Expansion - The company is committed to technological innovation, having successfully developed and launched 15 innovative TCM products that address major clinical treatment gaps [2]. - Yiling's products are included in over 200 clinical diagnosis and treatment guidelines, indicating their acceptance in the medical community [2]. - The approval of "Methylphenidate Hydrochloride" for market sale is expected to enrich the company's product line, particularly in treating moderate to severe Alzheimer's disease, aligning with the growing market demand due to aging populations [5]. Group 3: Financial and Trading Information - On November 12, Yiling Pharmaceutical's stock closed at 20.01 yuan, down 2.25%, with a trading volume of 668,600 shares and a turnover of 1.345 billion yuan [1]. - The net inflow of main funds was 23.33 million yuan, indicating increased short-term interest in the stock [3][4].
以岭健康携怡梦、津力旺等健康产品亮相链博会
Sou Hu Wang· 2025-07-17 07:29
Core Viewpoint - The third China International Supply Chain Promotion Expo (Chain Expo) was held from July 16 to 20 in Beijing, focusing on the theme "Linking the World, Creating the Future" and showcasing various sectors including advanced manufacturing, clean energy, smart vehicles, digital technology, health living, and green agriculture, attracting 651 companies and organizations from 75 countries and regions [1][10] Company Overview - Yiling Health participated in the Chain Expo, showcasing innovative health products in the "Health Living Chain" exhibition area, demonstrating its development cluster from medicine to health [1][3] Health Industry Focus - The "Health Living Chain" exhibition area emphasizes key products and technologies in the health sector, promoting a green and healthy lifestyle while supporting consumption and domestic demand [3] - Yiling Health's strategy aligns with this focus, integrating traditional medicine and health practices to create a comprehensive health management solution covering all life stages [3][4] Product Innovation - Yiling Health has developed a diverse range of health products to address common health issues such as high blood sugar, abnormal blood lipids, and sleep disorders, reflecting a shift from treatment-centered to health management-centered approaches [4][6] - Key products showcased include: - **Yimeng Beverage**: Targets blood lipid levels and sleep quality using a blend of five medicinal ingredients [4] - **Jinliwang Beverage**: A sugar-free drink designed for blood sugar management, utilizing six medicinal ingredients [6] - **Wanbi'an Soft Capsules**: Aimed at improving sleep quality, featuring the traditional calming herb sour jujube seed [6] Comprehensive Health Solutions - Yiling Health's product matrix extends beyond blood sugar and lipid management to include hypertension, weight loss, anti-aging, immune enhancement, fatigue resistance, and bone health, promoting proactive health management [7] - The company emphasizes the importance of managing health risks early to prevent chronic diseases, advocating for a philosophy of "health needs management" [7] Quality Assurance in Production - Yiling Health ensures product quality through strict control of traditional Chinese medicine materials, establishing a collaborative model with local farmers to guarantee the authenticity and quality of raw materials [8] - The company has built over 60 high-standard medicinal herb cultivation bases across major regions in China, covering more than 40 varieties of traditional Chinese medicine [8][9] Future Outlook - Yiling Health aims to leverage the Chain Expo to deepen exchanges and share its experiences in building a full lifecycle service industry chain in traditional Chinese medicine, exploring new paths and models for health industry development [10]
端午节怎么玩?来以岭健康安康市集解锁不一样的节日氛围
Sou Hu Wang· 2025-05-31 09:11
Group 1 - The event "Traditional Chinese Medicine (TCM) Nurturing Vitality and Dragon Boat Festival Praying for Health" was held from May 31 to June 2, integrating traditional customs with TCM culture in a vibrant health festival [1][2] - The historical site Yanghe Tower served as a cultural landmark, showcasing the fusion of history and modern health practices, allowing citizens to experience the depth of TCM culture [2][3] Group 2 - The event featured a TCM cultural corridor with two main exhibition areas focusing on "Origin of Meridian Diseases" and "Nurturing Vitality," presenting the TCM meridian theory and the essence of health from Confucianism, Buddhism, Taoism, and medicine [3][4] - Cultural performances included the "Chinese Meridian Exercise," which combined TCM theory with traditional health practices, promoting physical well-being through movement [4][6] Group 3 - Interactive experiences were provided, including free TCM consultations where experts offered personalized health advice based on individual conditions, along with free tastings of herbal beverages [6][7] - The event also featured a DIY section for making herbal sachets, allowing families to engage with TCM traditions and understand the practical applications of ancient wisdom [8][10] Group 4 - A series of lectures on the "Eight Principles of Meridian Health" were conducted, emphasizing the importance of meridian health, energy nurturing, appropriate exercise, and mental well-being [10] - The initiative aimed to modernize TCM and make it appealing to younger generations, promoting a cultural revival and health awareness among the public [10]
以岭药业:坚持科技驱动战略 拥有17个创新专利中药、覆盖心脑血管等七大疾病领域
Quan Jing Wang· 2025-05-12 11:58
Core Viewpoint - Yiling Pharmaceutical has made significant advancements in the field of traditional Chinese medicine, particularly in the development of the "Luo Disease Theory," which is now recognized as a major milestone in the history of Chinese medicine research [1][2]. Group 1: Luo Disease Theory Development - The company has systematically constructed the Luo Disease Theory, marking it as the "fourth milestone" in the history of Luo Disease research, following significant historical contributions [1]. - Yiling Pharmaceutical has published three key works: "Luo Disease Studies," "Pulse and Vessels Theory," and "Qi and Vessels Theory," which form the theoretical framework for Luo Disease treatment [1]. Group 2: Technological Innovation and Research - The company has established a national key laboratory for the innovation and transformation of Luo Disease Theory, leading to the formation of a research team headed by academicians and experts [2]. - Yiling Pharmaceutical has developed 17 innovative patented traditional Chinese medicines targeting seven major disease areas, including cardiovascular and respiratory diseases [2]. - The company has undertaken over 60 national and provincial-level research projects and completed more than 40 evidence-based medical studies, receiving six major national science and technology awards [2]. Group 3: Cardiovascular Disease Research - In the cardiovascular field, the company has developed three innovative patented traditional Chinese medicines: Tongxinluo Capsules, Shengsongyangxin Capsules, and Qiliqiangxin Capsules, addressing common ischemic cardiovascular diseases, arrhythmias, and heart failure [2]. - The company has successfully completed five evidence-based medical studies related to the prevention and treatment of cardiovascular event chains, with the project receiving an "excellent" performance evaluation [2]. Group 4: Anti-Aging Products - The company has launched the OTC product Baizi Bujin Capsules, which is designed to combat aging by replenishing kidney essence and balancing yin and yang [3]. - Research conducted by several authoritative institutions has shown that Baizi Bujin Capsules not only have anti-aging effects but also provide preventive treatment for various chronic diseases caused by aging [3].